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Abstract Autosomal dominant renal hypomagnesemia
(OMIM 154020), associated with hypocalciuria, has been
linked to a 121G to A mutation in the FXYD2 gene. To gain
insight into the molecular mechanisms linking this muta-
tion to the clinical phenotype, we studied isolated proximal
tubular cells from urine of a patient and a healthy subject.
Cells were immortalized and used to assess the effects of
hypertonicity-induced overexpression of FXYD2 on
amount, activity and apparent affinities for Na?, K? and
ATP of Na,K-ATPase. Both cell lines expressed mRNA for
FXYD2a and FXYD2b, and patient cells contained both
the wild-type and mutated codons. FXYD2 protein
expression was lower in patient cells and could be
increased in both cell lines upon culturing in hyperosmotic
medium but to a lesser extent in patient cells. Similarly,
hyperosmotic culturing increased Na,K-ATPase protein
expression and ATP hydrolyzing activity but, again, to a
lesser extent in patient cells. Apparent affinities of Na,K-
ATPase for Na?, K? and ATP did not differ between
patient and control cells or after hyperosmotic induction.
We conclude that human proximal tubular cells respond to
a hyperosmotic challenge with an increase in FXYD2 and
Na,K-ATPase protein expression, though to a smaller
absolute extent in patient cells.
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Introduction
Autosomal dominant renal hypomagnesemia (OMIM
154020), associated with hypocalciuria, is a disorder which
has been linked to a 121G to A mutation in the FXYD2
gene (Meij et al. 2000). This mutation leads to a G41R
substitution in the transmembrane domain of the FXYD2
protein (Na,K-ATPase c-subunit). FXYD2 belongs to a
family of seven mammalian members, all of which share
the FXYD motif in the N-terminal domain. All family
members have been shown to be able to associate with
Na,K-ATPase and to alter its intrinsic properties (Crambert
et al. 2002, 2005; Lubarski et al. 2005; Delprat et al. 2007;
Beguin et al. 1997, 2001, 2002; Li et al. 2005; Ary-
starkhova et al. 1999; Therien et al. 1999). This together
with their tissue-specific expression pattern has led to the
hypothesis that they function as cell- and tissue-specific
regulators of Na,K-ATPase.
Association of FXYD2 with Na,K-ATPase alters the
apparent affinity for K? in a membrane potential–depen-
dent manner (Arystarkhova et al. 1999; Beguin et al. 1997)
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and reduces Na? affinity (Arystarkhova et al. 1999; Beguin
et al. 2001). The apparent affinity for ATP is also altered
(Therien et al. 1999). The G41R substitution in the trans-
membrane domain of FXYD2, which is linked to hypo-
magnesemia, has been demonstrated to disrupt the
association between Na,K-ATPase and FXYD2 (Meij et al.
2003; Pu et al. 2002). The molecular mechanism by which
this lack of association leads to hypomagnesemia is not yet
resolved. Thus far, studies of these molecular mechanisms
have been hampered by the absence of a suitable human
renal cell model. This limitation can, in principle, be
overcome by the possibility of culturing renal cells derived
from urine (Laube et al. 2005; Racusen et al. 1995).
In the present study, we cultured and characterized
proximal tubular epithelial cells (PTECs) immortalized
with human papillomavirus E6/E7 genes (HPV16 E6/E7)
from the urine of a hypomagnesemia patient and compared
their properties with those of cells derived from the urine of
a healthy control. To this end, we determined the expres-
sion levels of FXYD2 and the Na,K-ATPase a-subunit, the
maximum ATPase activity and the apparent Na?, K? and
ATP affinities of Na,K-ATPase under normo- and hyper-
osmotic culturing conditions. We show that the Na,K-
ATPase a-subunit and FXYD2 can be upregulated by
exposing the cells to hyperosmolality, yet the absolute
expression levels remain lower in patient cells compared to
control cells. The increase in Na,K-ATPase expression is
proportionate to an increase in maximal Na,K-ATPase
activity, whereas it is not accompanied by changes in the
apparent affinities for Na?, K? or ATP of the enzyme.
Materials and Methods
PTE Cell Line Generation
Urine was collected from a patient (35 years old, male) in
whom the G41R mutation was confirmed previously (Meij
et al. 2000) and used to obtain proximal tubular cells. Urine
of a healthy subject (12 years old, male) was used for
obtaining control proximal tubular cells. Proximal tubular
cells were isolated as described previously (Wilmer et al.
2005). Urine was centrifuged (2239g, 5 min, room tem-
perature) within 5 h after collection. After washing in
phosphate-buffered saline (PBS) and a second centrifugation
step, urine sediment was resuspended in 3 ml PTEC culture
medium (DMEM–Ham’s F12; Cambrex Biosciences, East
Rutherford, NJ) supplemented with 10% fetal calf serum
(FCS), 100 U/ml penicillin (GIBCO, Grand Island, NY),
100 U/ml streptomycin (GIBCO), ITS (Sigma, St. Louis,
MO; 5 lg/ml insulin, 5 lg/ml transferrin and 5 ng/ml sele-
nium), 36 ng/ml hydrocortisone (Sigma), 10 ng/ml epider-
mal growth factor (EGF, Sigma) and 40 pg/ml
triiodothyronine (Detrisac et al. 1984). The suspension was
transferred to a 25-cm2 tissue culture flask and placed at 37C
in a 5% CO2 incubator. The medium was refreshed every 2–
3 days. To maintain proliferation, cells at passage 4 or less
were transfected with plasmid DNA, containing the HPV16
E6/E7 genes, using the amphotropic packaging cell line PA
317 (Ryan et al. 1994). The proximal tubular origin of cul-
tured cells was confirmed by visual morphology and by flow-
cytometric analysis using CD13 (aminopeptidase N) anti-
bodies, specific for PTECs.
Cell Culture
Cells were cultured at 37C in a humidified 5% CO2/95%
air atmosphere in PTEC culture medium (osmolality 286–
356 mosmol/kg H2O), supplemented with 50 mg/ml gen-
tamycin (GIBCO). For hyperosmotic induction of FXYD2,
cells were grown to 100% confluence, after which they
were grown for another 2 days in medium supplemented as
indicated in ‘‘Results.’’ Care was taken not to cause
changes in the pH of the culture medium. Patient and
control cells were analyzed under the same conditions, to
exclude experimental artifacts.
RNA Isolation and cDNA Synthesis
Cells were harvested by trypsinization, washed in PBS
(5009g, 1 min, 4C) and resuspended in 500 ll TRIzol
(Invitrogen, Carlsbad, CA). After addition of 50 ll chlo-
roform and 0.2 mg/ml glycogen, the suspension was vor-
texed for 10 s, incubated for 10 min at 4C, vortexed again
and centrifuged (12,0009g, 10 min, 4C). Clear superna-
tant (200 ll) was transferred to a small tube and 200 ll of
propanol-2 was added. The suspension was vortexed for
10 s, incubated for 10 min at 4C, vortexed again and
centrifuged (16,0009g, 30 min, 4C). The RNA pellet was
washed in 70% EtOH, air-dried and taken up in 40 ll of
DEPC water. cDNA was synthesized using 300 ng of
isolated RNA as template and random primers.
FXYD2 cDNA Detection
FXYD2 cDNA was amplified for detection using specific
primers for human FXYD2a (atgactgggttgtcgatggacggt),
human FXYD2b (atggacaggtggtacctg) and the redundant
reverse primer for human FXYD2 (ttacggctcatcttcatt-
gatttg). PCR products were analyzed by agarose gel elec-
trophoresis and sequencing.
Crude Membrane Preparation
Cells were harvested by trypsinization, washed in PBS
(5009g, 1 min, 4C) and resuspended in 500 ll H2O
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containing protease inhibitor (1 tablet/10 ml, per the
manufacturer’s protocol; Roche, Indianapolis, IN). After
repeated freezing and thawing to lyse the cells, DNA was
broken down by incubation with 100 U/ml Turbo DNase
(10 min, 4C; Ambion, Austin, TX), after which the
membranes were isolated by centrifugation (16,0009g,
30 min, 4C). The pellet was resuspended in 50 ll PBS and
stored at -20C.
Membrane Preparation
Cells were harvested by incubation in PBS/10 mM EDTA
at 37C for 1 h, after which they were scraped from the
culture flasks and collected. After centrifugation (2,0009g,
5 min), the cell pellet was resuspended in 5 ml PBS/10 mM
EDTA (pH 7.0) containing protease inhibitor (per the
manufacturer’s recommendations). Cells were lysed by
repeated freezing and thawing and homogenized by pulling
through a needle. The homogenate was centrifuged
(2009g, 5 min), after which the membranes were isolated
from the supernatant by centrifugation (100,0009g,
60 min). The pellet was resuspended in 500 ll H2O,
lyophilized, taken up in 400 ll buffer (250 mM sucrose,
50 mM Tris–HCl [pH 7.0] and 2 mM EDTA) and stored at
-20C.
Protein Determination
Protein concentrations were quantified with the modified
Lowry method according to Peterson (1983) using bovine
serum albumin as a standard.
Western Blotting
Membrane fractions were solubilized in sample buffer and
analyzed on SDS–PAGE gels containing 15% acrylamide
according to Laemmli (1970). For immunoblotting, the
separated proteins were transferred to Immobilon-P mem-
branes (Millipore, Bedford, MA). FXYD2 subunits were
detected with an antibody against the C-terminal end (Or
et al. 1996), kindly provided by Dr. S. Karlish (Rehovot,
Israel), whereas the a-subunit of Na,K-ATPase was
detected with antibody C356-M09 (Koenderink et al.
2003). Primary antibodies were detected using an anti-
rabbit secondary antibody, labeled with horseradish per-
oxidase (Dako, Copenhagen, Denmark).
ATPase Activity Assay
ATPase activity was determined using a radiochemical
method. For this purpose, 0.1 mg of membranes was added
to 100 ll of medium containing (in mM) 0.8 MgCl2, 0.1
EGTA, 0.2 EDTA, 1 TrisN3 and 50 Tris–HCl (pH 7.0), as
well as various concentrations of activating cations and
Mg-[c-32P]-ATP as indicated in ‘‘Results.’’ Ionic strength
was kept constant with choline chloride. After incubation
for 30 min at 37C, the reaction was stopped by adding
500 ll 10% (w/v) charcoal in 6% (v/v) trichloroacetic acid,
and after 10 min at 0C, the mixture was centrifuged for
10 s at 10,0009g. To 0.15 ml of clear supernatant, con-
taining the liberated inorganic phosphate (32Pi), 3 ml Op-
tiFluor (Canberra Packard, Tilburg, The Netherlands) was
added, and the mixture was analyzed by liquid scintillation
analysis. In general, blanks were prepared by incubating in
the absence of membranes. Na,K-ATPase activity is pre-
sented as the difference in activity between total ATPase
(cations as indicated) and Mg2?-ATPase (no Na? and K?
present, with 10 mM ouabain present).
Analysis of Data
Differences were tested for significance by means of Stu-
dent’s t-test. K0.5 values were determined by analyzing the
plots using the nonlinear curve-fitting program (Hill
equation function) of Origin 6.1 (OriginLab, Northhamp-
ton, MA).
Results
PTE Cell Line Generation
After culturing of urine sediments, colonies with cobble-
stone morphology appeared in urine samples of both
healthy control and hypomagnesemia subjects. Cultured
cells were immortalized by transfection with HPV E6/E7
genes. Although PETC markers were positive (see
‘‘Materials and Methods’’), we cannot with absolute cer-
tainty exclude mixed cell populations.
cDNA Characterization
RNA was isolated from patient and control cell lines, both
of which were induced by an increase in osmolality of
200 mosmol/kg H2O using sucrose. cDNA was synthesized
and subsequently analyzed by performing PCRs with
primers designed to pick up human FXYD2a and FXYD2b.
Analysis of the PCR products on agarose gel indicated the
presence of both FXYD2a and FXYD2b cDNA, which was
confirmed by sequencing (data not shown). Sequencing
furthermore revealed that the control cell line had only a
guanine at position 121, whereas the patient cell line had
both a wild-type guanine signal and a mutant adenine
signal in both FXYD2a (Fig. 1) and FXYD2b (data not
shown). The latter indicates that patient cells are hetero-
zygous and that both alleles are transcribed.
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Hyperosmotic Challenges
The crude membrane isolations of the cell lines were
analyzed on SDS–PAGE, to visualize the presence of
FXYD2 and the catalytic subunit (a) of Na,K-ATPase.
After several passages at normal osmolality, the amount of
FXYD2 in the membrane fractions diminished (data not
shown), in line with literature data (Capasso et al. 2001;
Wetzel et al. 2004) showing that various cell lines origi-
nating from the kidney do not express FXYD2 unless they
are exposed to hyperosmotic medium. Indeed, exposure of
our cell lines to hyperosmotic medium (raised by
200 mosmol/kg H2O with NaCl) raised the amount of
FXYD2 observed on Western blot, with little or no effect
on the amount of expressed a-subunit (Fig. 2, lanes 1 and
2). Exposure of the cells to an additional 200 mosmol/kg
H2O choline chloride (Fig. 2, lane 4) gave similar results as
200 mosmol/kg H2O NaCl. Exposure to an additional
200 mosmol/kg H2O sucrose (Fig. 2, lane 5) showed an
even larger increase in FXYD2 expression. In contrast,
exposure to neither an additional 200 mosmol/kg H2O
sodium acetate (Fig. 2, lane 3) nor 200 mosmol/kg H2O
urea (Fig. 2, lane 6) increased FXYD2 expression. In
addition, expression of FXYD2 seemed to be lower in
patient cells under all conditions compared to control cells.
Na,K-ATPase Expression and Activity
The presence of the a-subunit and FXYD2 in samples used
for ATPase activity measurements was visualized on
Western blot (Fig. 3). When cultured in hypertonic med-
ium (additional 200 mosmol/kg H2O sucrose), the relative
intensity of a-subunit and FXYD2 staining increased
1.7 ± 0.2-fold and 5 ± 1.0-fold for control cells and
1.3 ± 0.5-fold and 6.1 ± 2.3-fold for patient cells,
respectively. The expression level of FXYD2 in patient
cells was only 35 ± 10% of that in control cells (nor-
mosmotic conditions). Also, the expression levels of the
Na,K-ATPase a-subunit seemed to be higher in the control
cell line.
In the presence of ATP, Na? and K?, the total Na,K-
ATPase activity measured in isolated membranes increased
for both patient and control cells (Fig. 4a), though the
increase was less in the patient cells. Control fractions
showed a maximum activity of 2.86 ± 0.11 lmol Pi mg-1
protein h-1 from noninduced cultures and 4.89 ± 0.07 lmol
Pi mg-1 protein h-1 from induced cultures. The membraneFig. 1 Partial sequence of FXYD2. RNA isolation and cDNA
synthesis were performed as described in ‘‘Materials and Methods.’’
a Control products showing a wild-type guanine signal (arrow) in the
FXYD2a cDNA sequence. b Patient products showing a heterozygous
guanine and adenine signal (R, arrow) in the FXYD2a cDNA
sequence
Fig. 2 Expression of Na,K-ATPase a-subunit and FXYD2 in crude
membrane isolations of control and patient cell lines. Crude
membrane isolation and Western blot were performed as described
in ‘‘Materials and Methods.’’ Top labels show the rise in osmolality
compared to normal medium. Expression of FXYD2 is clearly
influenced by increasing the osmolality with the aid of NaCl, choline
chloride and sucrose compared to control samples. No or very minor
effects are seen with sodium acetate or urea. Shown is a represen-
tative of two experiments
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fractions from patient material showed a maximum activity
of 2.37 ± 0.24 lmol Pi mg-1 protein h-1 from noninduced
cultures and 3.02 ± 0.18 lmol Pi mg-1 protein h-1 from
induced cultures. Mg2?-ATPase activity, measured in the
absence of Na? and K? and in the presence of ouabain, was
virtually the same for control and patient material and did not
alter upon induction. When corrected for the relative inten-
sity of isolated a-subunit on Western blot (Fig. 3), the sam-
ples showed no significant differences in activity (Fig. 4b).
This finding indicates that the increase in ATPase activity
can be fully explained by the sucrose-induced increase in
Na,K-ATPase a-subunit expression.
In membrane samples from noninduced control cultures,
the apparent affinities for ATP (Fig. 5), Na? (Fig. 6) and
K? (Fig. 7) were 0.54 ± 0.05, 9.1 ± 0.8 and 1.38 ±
0.26 mM, respectively (Table 1). Essentially the same
values were found after induction with sucrose (0.51 ±
0.04, 8.7 ± 0.6 and 1.24 ± 0.1 mM, respectively). Corre-
sponding values obtained with samples from noninduced
(0.68 ± 0.07, 8.8 ± 0.7 and 1.79 ± 0.18 mM, respec-
tively) and induced (0.59 ± 0.05, 8.3 ± 0.9 and
1.61 ± 0.11 mM, respectively) patient cultures did not
significantly differ from control cultures.
Discussion
FXYD2 (Na,K-ATPase c-subunit) is a kidney-specific
regulator of Na,K-ATPase. Dominant renal hypomagne-
semia associated with hypocalciurea has been linked to a
121G ? A mutation in the FXYD2 gene, resulting in a
G41R substitution in the protein itself. Since the relation
between the mutation and hypomagnesemia is not under-
stood yet, we isolated proximal tubular cells from the urine
of a healthy control subject and a patient carrying the
above mutation and converted these into immortalized cell
lines. mRNA of both FXYD2a and FXYD2b was shown to
be present and the 121G to A mutation, associated with
hypomagnesemia, was detected in the patient cell line. At
the protein level we show that both cell lines contained
FXYD2 and the catalytic a-subunit of Na,K-ATPase. We
furthermore show that both proteins can be upregulated by
culturing the cells under hypertonic conditions.
The induction of FXYD2 in our cell lines is in agree-
ment with the literature (Capasso et al. 2001; Wetzel et al.
2004), as is the decline in FXYD2 protein over prolonged
time periods when normal medium is used. The absence of
any induction by 200 mM urea, which diffuses freely
through the cells, indicates that these cell lines express
FXYD2 particularly when cultured in an environment with
Fig. 3 Expression of Na,K-ATPase a-subunit and FXYD2 in isolated
membranes of control and patient cell lines. Membrane isolation and
Western blot were performed as described in ‘‘Materials and
Methods.’’ Equal amounts of protein were loaded per well. When
induced with an additional 200 mosmol/kg H2O of sucrose, indicated
by ??, expression of both subunits is enhanced. Shown are
means ± SE of three enzyme preparations
Fig. 4 Na,K-ATPase activity of
control and patient cell lines.
Na,K-ATPase activity for both
cell lines from both sucrose-
induced and noninduced
cultures in the presence of 3 mM
ATP, 10 mM K? and 100 mM
Na? (a). When ATPase activity
is corrected for a-subunit
expression (Fig. 3), all samples
show similar activity (b).
Shown are means ± SE of three
enzyme preparations
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extracellular hyperosmolality. This indicates the existence
of a regulatory system in which FXYD2 is upregulated to
modulate the function of Na,K-ATPase so that it better
suits the cellular environment. Moreover, upregulation of
FXYD2 is Na?-independent and Cl--dependent. This
result confirms the data of Capasso et al. (2003), who
showed that in IMCD3 cells chloride stimulates expression
of FXYD2 and activates JNK in response to hypertonicity.
On the mRNA level we show the presence of FXYD2a
and FXYD2b, as well as their mutated forms, in patient
cells. Unfortunately, the antibody used in this study cannot
distinguish between these two splice variants, nor can it
distinguish between wild-type and G41R mutant FYXD2.
Earlier work using recombinant protein obtained from
cRNA-injected Xenopus leavis oocytes revealed a distinct
difference in molecular mass between wild-type and
mutant protein on SDS–PAGE (Meij et al. 2003). How-
ever, in our isolated cells we could not detect this differ-
ence in molecular mass. A similar lack of difference in gel
migration was found in HeLa cells transfected with either
wild-type FXYD2b or G41R-mutated FXYD2b (Pu et al.
2002). We therefore cannot say with certainty that both
wild-type and mutant FXYD2 are present in protein form.
If the mutated FXYD2 is quickly degraded after upregu-
lation, only the wild-type FXYD2 will be observed. In
previous studies it was shown that the routing of FXYD2-
Fig. 5 Effects of ATP on Na,K-ATPase activity. ATPase activity
was measured in membrane preparations as described in ‘‘Materials
and Methods’’ in the presence of 0.1 mM EGTA, 0.2 mM EDTA,
0.8 mM MgCl2, 1.0 mM Tris–N3, 100 mM NaCl and 10 mM KCl, at pH
7.0. Ionic strength was kept constant with choline chloride. Samples
from noninduced cultures are represented by open symbols. Samples
from cultures induced with an additional 200 mosmol/kg H2O of
sucrose are represented by closed symbols. Shown are means ± SE of
three enzyme preparations
Fig. 6 Effects of NaCl on Na,K-ATPase activity. ATPase activity
was measured in membrane preparations as described in ‘‘Materials
and Methods’’ in the presence of 0.1 mM EGTA, 0.2 mM EDTA,
0.8 mM MgCl2, 1.0 mM Tris–N3, 10 mM KCl and 2.0 mM MgATP at
pH 7.0. Ionic strength was kept constant with choline chloride.
Samples from noninduced cultures are represented by open symbols.
Samples from cultures induced with an extra 200 mosmol/kg H2O of
sucrose are represented by closed symbols. Shown are means ± SE of
three enzyme preparations
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G41R is impaired and that it can prevent the correct routing
of wild-type FXYD2 (Meij et al. 2000; Cairo et al. 2008).
Immunohistochemical scanning of patient cells might
indicate if FXYD2 is indeed retarded. However, due to
high intracellular background signals with the current
antibody, we were unable to draw any conclusion about the
localization of FXYD2 (data not shown).
Na,K-ATPase activity measurements on isolated mem-
branes showed no significant changes in cation or ATP
affinities between the two cell lines, irrespective of
induction. The wild-type cell line showed a significant
increase in total ATPase activity, but this can be explained
by the increase in the total amount of Na,K-ATPase a-
subunit. When ATPase activity was corrected for the
amount of a-subunit detected on Western blot, all samples
displayed the same activity, regardless of origin or induc-
tion state, indicating that an increase in Na,K-ATPase
activity is due to upregulation of Na,K-ATPase. Whereas
these findings are in agreement with an earlier study in
which the a-subunit and subsequent activity were increased
in a primary culture of human proximal tubule cells
exposed to hypertonicity (Yordy and Bowen 1993), they
are at odds with studies performed by Wetzel et al. (2004).
The latter authors show a reduction in the maximal activity
of Na,K-ATPase after hyperosmotic induction of NRK-52E
cells in the presence of 10% FCS. We revealed stimulation
of Na,K-ATPase activity (also in the presence of 10%
FCS), which correlated with the amount of expressed a-
subunit. Whether this discrepancy is due to differences in
cell type or induction of FXYD2 splice variants is unclear.
The major difference we found between the patient and
control cell lines was the lower amount of FXYD2
expressed per milligram of protein in the isolated mem-
branes obtained from the patient cell line under the various
conditions compared to the control cell line under similar
conditions (Fig. 3). The mutated FXYD2 is retarded in the
Golgi network (Meij et al. 2003) and probably broken
down more rapidly than the wild-type FXYD2. In hetero-
zygous cells, oligomers between wild-type and mutant
FXYD2 may be unable to leave the Golgi network, leading
to increased breakdown (Cairo et al. 2008). Recently, it
was shown that FXYD2 and the Na,K-ATPase a-subunit do
not traffic together to the plasma membrane and, thus,
assemble at the plasma membrane to form a complex (Pi-
hakaski-Maunsbach et al. 2008). We therefore can con-
clude that the reduced Na,K-ATPase response to
hypertonicity in patient cells is not due to interaction with
the mutated FXYD2. It is likely that the absolute decrease
of hyperosmolarity induced upregulation of FXYD2 and
that the Na,K-ATPase a-subunit in isolated patient cells
also happens in vivo. Reduced overexpression of the
FXYD2 subunit in response to hypertonic stress can affect
cell survival or might lead to changes in intracellular ATP
levels (Capasso et al. 2006). Eventually, this decrease of
Fig. 7 Effects of KCl on Na,K-ATPase activity. ATPase activity was
measured in membrane preparations as described in ‘‘Materials and
Methods’’ in the presence of 0.1 mM EGTA, 0.2 mM EDTA, 0.8 mM
MgCl2, 1.0 mM Tris-N3, 100 mM NaCl and 2.0 mM MgATP, at pH
7.0. Ionic strength was kept constant with choline chloride. Samples
from noninduced cultures are represented by open symbols. Samples
from cultures induced with an extra 200 mosmol/kg H2O of sucrose
are represented by closed symbols. Shown are means ± SE of three
enzyme preparations
Table 1 Apparent Na,K-ATPase affinities for ATP, Na? and K? of
membrane samples from noninduced control cultures, induced control







Control -- 0.54 ± 0.05 9.1 ± 0.8 1.38 ± 0.26
Control ?? 0.51 ± 0.04 8.7 ± 0.6 1.24 ± 0.10
Patient -- 0.68 ± 0.07 8.8 ± 0.7 1.79 ± 0.18
Patient ?? 0.59 ± 0.05 8.3 ± 0.9 1.61 ± 0.11
Values are derived from Figs. 5, 6, and 7
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upregulation will have adverse effects on magnesium
homeostasis by some hitherto unknown mechanism.
Although we discuss only two single cell lines here, we
analyzed the first cell line to be created from cells isolated
from the urine of a patient with the G41R mutation linked to
dominant renal hypomagnesemia associated with hypocal-
ciuria. We show that FXYD2 can be induced in these cells
and that in hypertonically challenged patient cells the
amount of Na,K-ATPase a-subunit and FXYD2 is reduced.
As such, these cell lines represent a valuable tool for research
into the disorder. Isolating and producing cell lines from
other patients is the next step for future experiments.
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